VarCov Co’s KalVista Pharmaceuticals KALV Stock Holding History

VarCov Co’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,108	Closed	-$264K	–	467
2026 Q1	$264K	Buy	+13,108	New	+$211K	0.1%	303

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VarCov Co's KALV Position: Q2 2026 in Review

VarCov Co sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 13,108 shares — an estimated $264K sold.

VarCov Co first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $264K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

VarCov Co reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 13,108 KalVista Pharmaceuticals shares in Q2 2026, an estimated $264K.
VarCov Co first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
VarCov Co's KalVista Pharmaceuticals position peaked at $264K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.